American Century Companies Inc. Boosts Holdings in STERIS plc (NYSE:STE)

American Century Companies Inc. raised its position in STERIS plc (NYSE:STE - Free Report) by 10.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 369,698 shares of the medical equipment provider's stock after acquiring an additional 35,424 shares during the quarter. American Century Companies Inc. owned approximately 0.37% of STERIS worth $75,995,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of STE. Avalon Trust Co purchased a new position in STERIS during the 4th quarter valued at about $30,000. Human Investing LLC bought a new stake in shares of STERIS in the 4th quarter worth approximately $31,000. Anfield Capital Management LLC increased its stake in shares of STERIS by 100.0% during the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock valued at $37,000 after buying an additional 91 shares during the period. Central Pacific Bank Trust Division raised its holdings in shares of STERIS by 65.5% during the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock valued at $39,000 after acquiring an additional 76 shares in the last quarter. Finally, Manchester Capital Management LLC lifted its stake in STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock worth $44,000 after acquiring an additional 137 shares during the period. 94.69% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research analysts have issued reports on the stock. Piper Sandler boosted their price objective on shares of STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research report on Monday, February 3rd. JMP Securities reiterated a "market outperform" rating and set a $265.00 price target on shares of STERIS in a research report on Thursday, February 6th. Finally, Stephens reissued an "overweight" rating and issued a $240.00 price target on shares of STERIS in a research note on Thursday, February 6th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $258.75.

Remove Ads

STERIS Stock Up 0.6 %

STERIS stock traded up $1.29 on Thursday, hitting $224.35. 503,563 shares of the stock traded hands, compared to its average volume of 503,714. STERIS plc has a 1 year low of $197.82 and a 1 year high of $248.24. The firm has a market cap of $22.04 billion, a P/E ratio of 47.63 and a beta of 0.92. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. The business's fifty day simple moving average is $222.24 and its 200 day simple moving average is $221.63.

STERIS (NYSE:STE - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. As a group, sell-side analysts forecast that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were paid a $0.57 dividend. The ex-dividend date was Thursday, February 20th. This represents a $2.28 annualized dividend and a dividend yield of 1.02%. STERIS's payout ratio is currently 48.41%.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.